日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Racial/Ethnic Disparities and Immunotherapeutic Advances in the Treatment of Hepatocellular Carcinoma

种族/民族差异与肝细胞癌治疗中的免疫治疗进展

Garcia, Alexsis; Mathew, Stephen O

Differential Expression of LLT1, SLAM Receptors CS1 and 2B4 and NCR Receptors NKp46 and NKp30 in Pediatric Acute Lymphoblastic Leukemia (ALL)

儿童急性淋巴细胞白血病(ALL)中LLT1、SLAM受体CS1和2B4以及NCR受体NKp46和NKp30的差异表达

Powers, Sheila B; Ahmed, Nourhan G; Jose, Roslin; Brezgiel, Marissa; Aryal, Subhash; Bowman, W Paul; Mathew, Porunelloor A; Mathew, Stephen O

Withaferin A: A Pleiotropic Anticancer Agent from the Indian Medicinal Plant Withania somnifera (L.) Dunal

醉茄素A:一种来自印度药用植物睡茄(Withania somnifera (L.) Dunal)的多效性抗癌剂

Kumar, Suneel; Mathew, Stephen O; Aharwal, Ravindra Prasad; Tulli, Hardeep Singh; Mohan, Chakrabhavi Dhananjaya; Sethi, Gautam; Ahn, Kwang-Seok; Webber, Kassidy; Sandhu, Sardul Singh; Bishayee, Anupam

Natural Killer Cell-Mediated Immunotherapy for Leukemia

自然杀伤细胞介导的白血病免疫疗法

Allison, Michaela; Mathews, Joel; Gilliland, Taylor; Mathew, Stephen O

A novel ligand on astrocytes interacts with natural cytotoxicity receptor NKp44 regulating immune response mediated by NK cells

星形胶质细胞上的一种新型配体与天然细胞毒性受体NKp44相互作用,调节NK细胞介导的免疫反应。

Bowen, Kelly E; Mathew, Stephen O; Borgmann, Kathleen; Ghorpade, Anuja; Mathew, Porunelloor A

Overexpression of LLT1 (OCIL, CLEC2D) on prostate cancer cells inhibits NK cell-mediated killing through LLT1-NKRP1A (CD161) interaction.

前列腺癌细胞上 LLT1 (OCIL, CLEC2D) 的过度表达通过 LLT1-NKRP1A (CD161) 相互作用抑制 NK 细胞介导的杀伤作用

Mathew Stephen O, Chaudhary Pankaj, Powers Sheila B, Vishwanatha Jamboor K, Mathew Porunelloor A